KIDNEY TRANSPLANTATION
Clinical trials for KIDNEY TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANTATION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Kidney transplant breakthrough? study aims to free patients from lifelong drugs
Disease control TerminatedThis study tested a combination of an experimental drug (siplizumab), donor bone marrow cells, and mild chemotherapy in 4 kidney transplant patients. The goal was to see if this approach could help the body accept the new kidney without needing lifelong anti-rejection medication.…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated May 26, 2026 02:18 UTC
-
Kidney transplant study tests easier daily pill routine
Disease control TerminatedThis study looked at whether a simpler, once-daily medication plan (using EnvarsusXR and azathioprine) works as well as the standard twice-daily plan for preventing kidney rejection after transplant. It involved 20 adult kidney transplant patients at low risk for rejection. The s…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE4 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Can a drug switch after kidney transplant reduce Long-Term risks?
Disease control TerminatedThis study looked at whether switching kidney transplant patients from tacrolimus to sirolimus (both with mycophenolate mofetil) could lower the risk of kidney damage, new diabetes, and cancer. It involved 65 stable transplant recipients between 12 and 36 months after surgery. Th…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New kidney transplant drug trial halted early
Disease control TerminatedThis study tested a new medicine called TCD601 (Siplizumab) in people receiving a new kidney. The goal was to see if it is safer and works better than a standard treatment (rATG) to prevent the body from rejecting the new kidney. The study included 33 adults aged 18 to 70 who got…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE2 • Sponsor: ITB-Med LLC • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New ultrasound technique aims to spot kidney transplant problems early
Knowledge-focused TerminatedThis study tested a special ultrasound technique that uses a contrast dye to get clearer images of a new kidney after transplant. The goal was to see if this method could help doctors find early signs of complications, like delayed function or rejection. The study included 20 adu…
Matched conditions: KIDNEY TRANSPLANTATION
Phase: PHASE1 • Sponsor: University of Utah • Aim: Knowledge-focused
Last updated May 26, 2026 02:09 UTC